ACCC publishes white paper on integrated health care systems

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THE ASSOCIATION OF COMMUNITY CANCER CENTERS published a white paper, titled “What Will It Take? Five Essential Actions to Achieve a Positive Impact on Patient Care in the Integrated Healthcare Environment,” at its 32nd National Oncology Conference, addressing patient care in a changing provider setting.

The five actions described in the white paper are: aligning stakeholders and requiring accountability; defining quality in a value-based reimbursement system and providing access to quality care; using non-traditional delivery systems such as telehealth and primary care physicians and non-physician providers to deliver cancer care; integrating the use of big data to drive treatment decisions; and moving to patientdirected care in which the patient is at the center of all decisions and systemic change.

“Increased integration will impact all aspects of an organization’s cancer care delivery — cultural, operational, clinical and financial,” said ACCC President Steven D’Amato. “Our focus in this newly integrated environment is to provide education for hospital systems and physician practices on how to offer the best collaborative oncology care in a seamless way for patients.”

YOU MAY BE INTERESTED IN

Just consider for a minute if this was the first year of running your lab, if you were on the job market as a physician or scientist right now, if you were a resident contemplating a career in cancer research after fellowship, if you were a graduate student or postdoc, if you were an undergraduate or a technician who was looking toward graduate school.
The immune system can be a powerful tool to control cancer. Immune cells within our body detect cancer cells and release payloads that kill them. Transformative science in the last decade has led to the development of therapies that enhance the ability of our immune cells to carry out this function. These therapies, including checkpoint blockade and CAR-T cells, have been lifesaving for many patients that before had untreatable cancer. But, sadly, a majority of patients with advanced solid tumors still succumb to their disease. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login